Mkts

ABVC BioPharma, Inc.

NASDAQ: ABVC
$0.91-0.05 (-5.56%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
0.860.98
52-week range
0.713.06
Today
Open0.97
Previous close0.91
Volume—
Valuation
Market cap24.55M
P/E ratio—
EPS (TTM)-0.32
Income & risk
Dividend / yield—
Beta0.46
Avg volume96.3K
Discussion

ABVC News

Stories mentioning ABVC from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue796.003.00389.00117.00
Cost of Goods Sold1.000.000.00
Gross Profit0.00(796.00)796.000.000.002.00389.00117.00
Operating Expenses
Research & Development33.0029.0030.0033.0029.0032.0038.0040.00
Sales General & Admin752.00784.00798.00690.00615.00311.00558.00654.00
Total Operating Expenses1,5722,1991,9642,295693.00707.00691.00977.00
Operating Income (Loss)(1,572)(2,995)(1,168)(2,295)(693.00)(705.00)(302.00)(860.00)
Interest Income4.0082.0047.0019.0019.0012.0044.0027.00
Interest Expense
Other Expense(1.00)(11.00)2.00(7.00)2.0089.00(7.00)33.00
Pretax Income(1,690)(3,813)(1,287)(2,309)(944.00)(797.00)(487.00)(1,158)
Tax Provision1.0024.000.00(111.00)
Net Income (Loss)(1,560)(3,563)(1,247)(2,257)(842.00)(732.00)(395.00)(942.00)
Earnings Per Share (Basic)(0.06)(0.18)(0.05)(0.13)(0.06)(0.06)(0.03)(0.08)
Earnings Per Share (Diluted)(0.06)(0.18)(0.05)(0.13)(0.06)(0.06)(0.03)(0.08)
Weighted Average Shares Outstanding (Basic)25,44920,10923,25717,38714,96811,67412,40511,321
Weighted Average Shares Outstanding (Diluted)25,44920,10923,25717,38714,96811,67412,40511,321

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ABVC

ABVC BioPharma, Inc. (NASDAQ: ABVC) is a stock listed on the Nasdaq Stock Market under the ticker symbol ABVC. It last traded at $0.9100 (Nov 13, 2026, 4:00 PM ET), down 5.6% on the day. That gives ABVC BioPharma a market capitalisation of $24.5M.

Over the past 52 weeks ABVC has traded between $0.7100 and $3.06.

For the quarter ended Mar 31, 2026 it reported a net loss of $1.6M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$1.6M—
Dec 31, 2025—-$3.6M—
Sep 30, 2025$796.0K-$1.2M-156.7%
Jun 30, 2025—-$2.3M—

From ABVC BioPharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…